All terms in BAO
| Label | Id | Description |
|---|---|---|
| lethal midline granuloma | DOID_9072 | |
| IN Cell Investigator | BAO_0180009 | |
| Cellomics BioApplication | BAO_0180006 | |
| CellProfiler | BAO_0180005 | |
| systemic lupus erythematosus | DOID_9074 | [A lupus erythematosus that is an inflammation of connective tissue marked by skin rashes, joint pain and swelling, inflammation of the kidneys and inflammation of the tissue surrounding the heart.] |
| Fiji | BAO_0180008 | |
| DCILabs | BAO_0180007 | |
| BD AttoVision | BAO_0180002 | |
| Acapella | BAO_0180001 | |
| BioImageXD | BAO_0180003 | |
| tolerogen | CHEBI_73623 | |
| central neurocytoma | DOID_14174 | |
| von Hippel-Lindau disease | DOID_14175 | |
| hemangioblastoma | DOID_5241 | |
| macroglobulinemia | DOID_9080 | |
| EC 2.1.1.37 [DNA (cytosine-5-)-methyltransferase] inhibitor | CHEBI_90190 | |
| congenital hypogammaglobulinemia | DOID_14177 | |
| EC 2.5.1.31 {ditrans,polycis-undecaprenyl-diphosphate synthase [(2E,6E)-farnesyl-diphosphate specific]} inhibitor | CHEBI_85618 | |
| Bruton-type agammaglobulinemia | DOID_14179 | [A B cell deficiency that is that has material basis in a mutation in the Bruton's tyrosine kinase (BTK) gene on the X chromosome resulting in X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement.] |
| c-Met tyrosine kinase inhibitor | CHEBI_90199 |